Anti-Inflammatory Effect of Fluvastatin on IL-8 Production Induced by Pseudomonas aeruginosa and Aspergillus fumigatus Antigens in Cystic Fibrosis
Open Access
- 3 August 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (8) , e22655
Abstract
Early in life, patients with cystic fibrosis (CF) are infected with microorganisms including bacteria and fungi, particularly Pseudomonas aeruginosa and Aspergillus fumigatus. Since recent research has identified the anti-inflammatory properties of statins (besides their lipid-lowering effects), we investigated the effect of fluvastatin on the production of the potent neutrophil chemoattractant chemokine, IL-8, in whole blood from CF patients, stimulated by Pseudomonas aeruginosa (LPS) and Aspergillus fumigatus (AFA) antigens. Whole blood from adult patients with CF and from healthy volunteers was collected at the Rennes University Hospital (France). Blood was pretreated for 1 h with fluvastatin (0–300 µM) and incubated for 24 h with LPS (10 µg/mL) and/or AFA (diluted 1/200). IL-8 protein levels, quantified by ELISA, were increased in a concentration-dependent manner when cells were stimulated by LPS or AFA. Fluvastatin strongly decreased the levels of IL-8, in a concentration-dependent manner, in whole blood from CF patients. However, its inhibitory effect was decreased or absent in whole blood from healthy subjects. Furthermore, the inhibition induced by fluvastatin in CF whole blood was reversed in the presence of intermediates within the cholesterol biosynthesis pathway, mevalonate, farnesyl pyprophosphate or geranylgeranyl pyrophosphate that activate small GTPases by isoprenylation. For the first time, the inhibitory effects of fluvastatin on CF systemic inflammation may reveal the important therapeutic potential of statins in pathological conditions associated with the over-production of pro-inflammatory cytokines and chemokines as observed during the manifestation of CF. The anti-inflammatory effect could be related to the modulation of the prenylation of signalling proteins.Keywords
This publication has 54 references indexed in Scilit:
- Statin Treatment and Mortality in Bacterial Infections – A Systematic Review and Meta-AnalysisPLOS ONE, 2010
- Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and BeyondAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequencesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy VolunteersAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Cystic fibrosisThe Lancet, 2009
- Statins for infection and sepsis: a systematic review of the clinical evidenceJournal of Antimicrobial Chemotherapy, 2008
- Clinical Use of Ibuprofen is Associated with Slower FEV1 Decline in Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- High-Dose Ibuprofen in Cystic Fibrosis: Canadian Safety and Effectiveness TrialThe Journal of Pediatrics, 2007
- Rho GTPases as therapeutic targets for the treatment of inflammatory diseasesExpert Opinion on Therapeutic Targets, 2003
- Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell lineInternational Journal of Immunopharmacology, 1996